YORLENY SHERRIER-EDWARDS: Open Payments
NPI 1801860085 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 56 payments from 20 companies in 2025. Trend: 2023 $973 · 2024 $967 · 2025 $1,194
Food & beverage: $1,194
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $205 |
| PFIZER INC. | 12 | $177 |
| Eisai Inc. | 2 | $140 |
| Lilly USA, LLC | 7 | $130 |
| Exact Sciences Corporation | 4 | $78 |
| Seqirus USA Inc | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Amgen Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
Products named: Ozempic, Leqembi, NURTEC ODT, MOUNJARO, Cologuard Collection Kit, JARDIANCE, XIFAXAN, Flucelvax.
Industry payments across VA — which companies pay providers there.
